Listing 1 - 6 of 6
Sort by

Dissertation
Assessment of safety and inconsistency in the efficacy of anti-osteoarthritis medications : evidence from new meta-analyses and contribution to recommendations for clinical practice and clinical trials
Authors: ---
Year: 2019

Loading...
Export citation

Choose an application

Bookmark

Abstract


Dissertation
Comportement des cellules souches mésenchymateuses dans un milieu articulaire inflammatoire
Authors: --- --- --- --- --- et al.
Year: 2019 Publisher: Liège Université de Liège (ULiège)

Loading...
Export citation

Choose an application

Bookmark

Abstract

L'utilisation des cellules souches mésenchymateuses gagne du terrain en médecine vétérinaire dans le domaine de la médecine régénérative, notamment chez le chien et le cheval pour le traitement de pathologies articulaires inflammatoires dégénératives, comme l'ostéoarthrose, pour lesquelles le vétérinaire ne dispose pas actuellement de solution curative efficace dans son arsenal thérapeutique. Cependant le manque de recul sur l'efficacité de l'injection de ces cellules dans un micro-environnement soumis à l'inflammation pourrait mener à leur emploi inutile, voire délétère. Nous nous sommes donc demandé quel était l'état des lieux des connaissances sur le comportement des cellules souches mésenchymateuses dans un milieu articulaire soumis à l'inflammation. Si in-vitro l'exposition aux cytokines inflammatoires du liquide synovial module leurs sécrétions paracrines et l'expression des marqueurs membranaires, l'injection intra-articulaire sur des modèles d'ostéoarthrite démontre leur action anti-inflammatoire et immunomodulatrice sur les cellules résidentes, leur effet chondroprotecteur, mais aussi leur faible persistance dans le milieu intra-articulaire inflammé. Au niveau des résultats cliniques, si les cellules souches mésenchymateuses en intra-articulaire sont sûres et efficaces pour réduire en partie les signes cliniques de l'ostéoarthrose, les nombreuses variations de nature et de qualité des produits cellulaires utilisés empêche actuellement une évaluation objective de l'impact réel de ce traitement.


Book
Osteoarthritis Biomarkers and Treatments
Authors: --- ---
ISBN: 1789857384 1789857376 1839620986 Year: 2019 Publisher: IntechOpen

Loading...
Export citation

Choose an application

Bookmark

Abstract

This book presents exclusive and comprehensive insight into the detailed molecular mechanisms of osteoarthritis (OA) initiation, progression and current advancements in the field. Inputs from clinician scientists, research and expertise offer a complete explanation of the current understanding of the pathogenesis of OA and practice in imaging and treatments strategies. Contributions from leading scientists provide a detailed introduction in the use of biomarkers in clinical research as well as in clinical practice and OA diagnosis. This book further discusses the potential of regenerative therapies and recent advances in cardiovascular and functional capacity on patients with OA.


Book
Research of Pathogenesis and Novel Therapeutics in Arthritis
Author:
ISBN: 3038970662 3038970654 Year: 2019 Publisher: MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Arthritis has a high prevalence globally and includes over 100 different types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for arthritis patients. This book summarizes and discusses the global picture of the current understanding of arthritis.

Keywords

receptor activator of nuclear factor ?B --- infliximab --- tripterine --- triptolide --- osteoblast --- tumor necrosis factor-alpha --- synovial cell --- anti-arthritis --- biosimilars --- Epstein-Barr virus --- cytokines --- SOX9 --- parathyroid hormone --- nitric oxide --- rat --- etanercept --- angiogenesis --- glycosylation --- mitogen activated protein kinase --- Th9 lymphocytes --- rheumatoid arthritis --- IL-6 --- clodronate --- bone erosion --- mesenchymal stem cells --- collagen-induced arthritis --- biological --- gene expression --- inflammatory arthritis --- osteoarthritis --- fraxinellone --- nuclear factor kappa B --- messenger RNA --- inflammation --- miRNA --- disease-modifying --- adipokines --- WNT --- glycoprotein 42 --- miR-199a-5p --- proliferation --- next-generation sequencing --- collagen --- osteoarthritis (OA) --- experimental arthritis --- bone morphogenetic protein --- TNF-? --- computational modeling --- basic research --- osteoclast --- therapeutics --- certolizumab pegol --- chondrocytes --- progenitor cells --- adjuvant arthritis --- adalimumab --- triterpenoid --- sclareol --- TNF? --- fibroblast growth factor 2 --- antibodies --- osteoblasts --- molecular pathology --- Th17 --- immunology --- obesity --- visfatin --- articular cartilage --- autoimmune --- biomarkers --- celastrol --- MAPK --- disease pathways --- IL1? --- arthritis --- bioinformatics --- anticitrullinated peptide antibodies --- drug delivery system --- antagonists --- shared epitope --- pathology --- SMA- and MAD-related protein --- small-molecule inhibitor --- transforming growth factor ? --- mice --- golimumab --- spinal fusion --- antirheumatic drug --- early osteoarthritis --- stem cell --- rheumatoid factor --- therapeutic antibody --- bisphosphonate --- osteoclastogenesis --- interleukin --- spondyloarthropathies --- clinical translation --- therapy --- Traditional Chinese medicine --- chemokines --- structure --- cell signaling --- microRNA


Book
Blood-Derived Products for Tissue Repair/Regeneration
Authors: ---
ISBN: 3039218611 3039218603 Year: 2019 Publisher: MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

This Special Issue on “Blood-Derived Products for Tissue Repair and Regeneration” reveals the evolution and diversity of platelet rich plasma (PRP) technologies, which includes experimental research on novel formulations, the creation of combination therapies, and the exploration of potential modifiers of PRPs, as well as efficacy of PRP therapies in clinical veterinary and human applications. Scientist and clinicians are now starting to develop different treatments based on their reinterpretation of the traditional roles of platelets and plasma, and the current Issue has provided a forum for sharing research and ways of understanding the associated medicinal benefits from different points of view. The research interest in this area has covered different medical disciplines, such as ophthalmology, dentistry, orthopedics, and sports medicine.

Listing 1 - 6 of 6
Sort by